| 27/06/18 | 08:00:04 | 27 Jun 2018 | | Lynparza: significant PFS 1st-line ovarian cancer | RNS |
| 26/06/18 | 08:00:09 | 26 Jun 2018 | | Board Committee Changes | RNS |
| 22/06/18 | 08:00:05 | 22 Jun 2018 | | Publication of a Prospectus | RNS |
| 12/06/18 | 08:00:07 | 12 Jun 2018 | | Update: lanabecestat Phase III Alzheimer's trials | RNS |
| 08/06/18 | 18:30:26 | 8 Jun 2018 | | EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC | RNS |
| 08/06/18 | 08:00:06 | 8 Jun 2018 | | Director Declaration | RNS |
| 01/06/18 | 16:00:02 | 1 Jun 2018 | | Block listing Interim Review | RNS |
| 01/06/18 | 16:00:01 | 1 Jun 2018 | | Total Voting Rights | RNS |
| 01/06/18 | 12:00:01 | 1 Jun 2018 | | Director Declaration | RNS |
| 30/05/18 | 08:00:07 | 30 May 2018 | | Update on TERRANOVA PIII trial for Fasenra in COPD | RNS |
| 25/05/18 | 08:00:06 | 25 May 2018 | | AZ's Imfinzi: significant OS in Stage III nsclc | RNS |
| 21/05/18 | 08:00:12 | 21 May 2018 | | AZ regulatory submission in Japan for Forxiga | RNS |
| 21/05/18 | 08:00:08 | 21 May 2018 | | US FDA approves Lokelma for adult hyperkalaemia | RNS |
| 18/05/18 | 08:00:03 | 18 May 2018 | | AZN: Q1 2018 Results | RNS |
| 11/05/18 | 08:00:03 | 11 May 2018 | | AstraZeneca update on Fasenra PIII trial in COPD | RNS |
| 08/05/18 | 12:00:01 | 8 May 2018 | | EMA approves Lynparza: maintenance ovarian cancer | RNS |
| 08/05/18 | 08:00:08 | 8 May 2018 | | AZ and Luye Pharma enter agreement for Seroquel | RNS |
| 04/05/18 | 13:00:01 | 4 May 2018 | | Director Declaration | RNS |
| 01/05/18 | 16:00:05 | 1 May 2018 | | Total Voting Rights | RNS |
| 27/04/18 | 13:30:02 | 27 Apr 2018 | | AZ: positive CHMP for Tagrisso first-line nsclc | RNS |
| 24/04/18 | 08:00:06 | 24 Apr 2018 | | Issue of Equity - AstraZeneca | RNS |
| 24/04/18 | 08:00:06 | 24 Apr 2018 | | AstraZeneca:high level results of the ARCTIC trial | RNS |
| 19/04/18 | 08:00:04 | 19 Apr 2018 | | FDA approves Tagrisso for 1st-line use in NSCLC | RNS |
| 13/04/18 | 12:00:01 | 13 Apr 2018 | | Notice of AGM | RNS |
| 05/04/18 | 08:00:04 | 5 Apr 2018 | | Directorate Change | RNS |
| 03/04/18 | 16:00:02 | 3 Apr 2018 | | Total Voting Rights | RNS |
| 28/03/18 | 16:00:02 | 28 Mar 2018 | | Director/PDMR Shareholding | RNS |
| 26/03/18 | 16:00:01 | 26 Mar 2018 | | Director/PDMR Shareholding | RNS |
| 22/03/18 | 16:48:51 | 22 Mar 2018 | | Lokelma approved in the EU | RNS |
| 12/03/18 | 07:00:05 | 12 Mar 2018 | | ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE | RNS |
| 07/03/18 | 07:00:06 | 7 Mar 2018 | | Filing of Form 20-F with SEC | RNS |
| 06/03/18 | 11:00:01 | 6 Mar 2018 | | Annual Financial Report | RNS |
| 01/03/18 | 15:00:01 | 1 Mar 2018 | | Total Voting Rights | RNS |
| 23/02/18 | 12:35:02 | 23 Feb 2018 | | Lynparza CHMP for ovarian cancer maintainance | RNS |
| 19/02/18 | 07:00:03 | 19 Feb 2018 | | AstraZeneca's IMFINZI approved for Stage III nsclc | RNS |
| 15/02/18 | 07:00:05 | 15 Feb 2018 | | Selumetinib in NF1 gets FDA orphan drug status | RNS |
| 05/02/18 | 14:00:01 | 5 Feb 2018 | | Director/PDMR Shareholding | RNS |
| 02/02/18 | 07:00:04 | 2 Feb 2018 | | AZN: Full-Year 2017 Results | RNS |
| 01/02/18 | 15:00:02 | 1 Feb 2018 | | Total Voting Rights | RNS |
| 26/01/18 | 18:20:06 | 26 Jan 2018 | | AZ Reports Phase III Results for PT010 in COPD | RNS |
| 26/01/18 | 07:00:03 | 26 Jan 2018 | | AZ Reports Phase III Results for PT010 in COPD | RNS |
| 19/01/18 | 07:00:02 | 19 Jan 2018 | | ASTRAZENECA'S FASENRA RECEIVES APPROVAL IN JAPAN | RNS |
| 19/01/18 | 07:00:02 | 19 Jan 2018 | | LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER | RNS |
| 12/01/18 | 16:10:01 | 12 Jan 2018 | | FDA approves Lynparza for metastatic breast cancer | RNS |
| 10/01/18 | 15:10:01 | 10 Jan 2018 | | AstraZeneca's Fasenra approved in the EU | RNS |
| 02/01/18 | 15:00:02 | 2 Jan 2018 | | Total Voting Rights | RNS |
| 28/12/17 | 14:00:01 | 28 Dec 2017 | | Director/PDMR Shareholding | RNS |
| 18/12/17 | 07:00:04 | 18 Dec 2017 | | FDA accepts Tagrisso submission for 1st-line nsclc | RNS |
| 15/12/17 | 12:00:01 | 15 Dec 2017 | | Director/PDMR Shareholding | RNS |
| 01/12/17 | 15:00:01 | 1 Dec 2017 | | Block listing Interim Review | RNS |
